360 related articles for article (PubMed ID: 34931228)
1. Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis.
Stafford MYC; Willoughby CE; Walsh CP; McKenna DJ
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34931228
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis.
Yu A; Guo K; Qin Q; Xing C; Zu X
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 33635319
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis.
Wu XL; Zhang JW; Li BS; Peng SS; Yuan YQ
Medicine (Baltimore); 2017 Dec; 96(51):e9279. PubMed ID: 29390487
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
5. Elevated miR-21 is associated with poor prognosis in non-small cell lung cancer: a systematic review and meta-analysis.
Yuan Y; Xu XY; Zheng HG; Hua BJ
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4166-4180. PubMed ID: 30024605
[TBL] [Abstract][Full Text] [Related]
6. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN
J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer.
Liu JB; Yan YJ; Shi J; Wu YB; Li YF; Dai LF; Ma XT
Medicine (Baltimore); 2019 Jul; 98(29):e16193. PubMed ID: 31335671
[TBL] [Abstract][Full Text] [Related]
10. MiR-24-3p as a prognostic indicator for multiple cancers: from a meta-analysis view.
Wang H; Chen C; Ding K; Zhang W; Hou J
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33206184
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
Pan F; Mao H; Deng L; Li G; Geng P
Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis.
Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX
Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
[TBL] [Abstract][Full Text] [Related]
15. Role of MicroRNA-124 as a Prognostic Factor in Multiple Neoplasms: A Meta-Analysis.
Zhou Z; Lv J; Wang J; Yu H; Lu H; Yuan B; Han J; Zhou R; Zhang X; Yang X; Yang H; Lu Q; Li P
Dis Markers; 2019; 2019():1654780. PubMed ID: 31885731
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis.
Chao C; Sang C; Wang M; Wang Z; Li Y; Luo G; Zhang X
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31803920
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathologic significance of PLIN2 in cancers: A systematic review with meta-analysis.
Li ML; Luo HY; Quan ZW; Huang LT; Wang JH
Int J Biol Markers; 2023 Mar; 38(1):3-14. PubMed ID: 36604990
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.
Chen YL; Liu XL; Li L
BMC Cancer; 2021 Jan; 21(1):63. PubMed ID: 33446130
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
Rana S; Valbuena GN; Curry E; Bevan CL; Keun HC
Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of MicroRNA-196a in Asian Cancer Patients: a Meta-Analysis.
Cai X; Liu X; Lu N; Xiao M; Li Z
Clin Lab; 2016 Nov; 62(11):2257-2265. PubMed ID: 28164681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
